started · updated
Oxaloacetate supplement may reduce brain fog in breast cancer survivors
A small clinical study conducted by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests that oxaloacetate, a molecule naturally present in the body, may help alleviate cognitive impairment in breast cancer survivors.
The study, published in JCO Oncology Advances, focused on women with early-stage breast cancer who were one to five years post-diagnosis. Participants reported symptoms often referred to as “chemo brain” or “brain fog,” including difficulties with memory, concentration, fatigue, and planning.
During the eight-week trial, participants took 500 milligrams of oxaloacetate twice daily. Of the 18 women who joined, 16 completed the study. All 16 reported improvements in cognitive symptoms, with testing indicating gains in processing speed and executive function. Participants also reported reduced fatigue and improved physical functioning.
Researchers noted that while the results are promising, the study was limited by a small sample size and the absence of a placebo group, meaning a causal link cannot yet be established. The study aims to address the complex causes of cognitive decline, which may include chemotherapy, hormone treatments, and inflammation.
Entities
David Geffen School of Medicine at UCLA · Dr. Patricia Ganz · JCO Oncology Advances · UCLA Health Jonsson Comprehensive Cancer Center · oxaloacetate
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] An estimated 15% to 25% of breast cancer survivors experience persistent cognitive difficulties. www.news-medical.net
- [● 2 SOURCES] Sixteen women completed the eight-week study. knowridge.com · www.nouvelles-du-monde.com
- [● 2 SOURCES] Cognitive testing showed improvements in processing speed and executive function. knowridge.com · www.news-medical.net
- [● 2 SOURCES] Participants took 500 milligrams of oxaloacetate twice a day for eight weeks. knowridge.com · www.nouvelles-du-monde.com
- [○ 1 SOURCE] All 16 women who completed the study reported improvements in cognitive symptoms. knowridge.com
- [● 3 SOURCES] A study by UCLA Health Jonsson Comprehensive Cancer Center found oxaloacetate may improve cognitive function in breast cancer survivors. knowridge.com · www.nouvelles-du-monde.com · www.news-medical.net
- [● 3 SOURCES] The study involved 18 women with early-stage breast cancer who were one to five years past diagnosis. knowridge.com · www.nouvelles-du-monde.com · www.news-medical.net
- [○ 1 SOURCE] The study lacked a placebo group. knowridge.com